Most state Medicaid programs still restrict access to hepatitis C medicines

Most state Medicaid programs still restrict access to hepatitis C medicines

More reads

• Most state Medicaid programs continue to restrict access to Hepatitis C drugs. (STAT) 
• That big neurosciences R&D group Eli Lilly built is being dismantled, with layoffs and parts shipped home (Endpoints)
• Blueprint and Ipsen to work together on treatment for ultra-rare genetic disorder. (Boston Globe)
• Milasen: The drug that went from an idea to an injection in 10 months. (C&EN)